Skip to main content
TISSUE REGENIX GROUP PLC logo

TISSUE REGENIX GROUP PLC — Investor Relations & Filings

Ticker · TRX ISIN · GB00BNTXR104 LEI · 213800PNOD5UHQUFJI36 IL Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2026-02-23 Regulatory Filings
Country GB United Kingdom
Listing IL TRX

About TISSUE REGENIX GROUP PLC

https://www.tissueregenix.com/

Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine. The company develops and commercializes biological products designed to repair and regenerate human tissue. It employs proprietary decellularization platform technologies to process human and animal tissues, creating acellular scaffolds. When implanted, these scaffolds support the patient's own cells in repopulating and regenerating the damaged area. The company's portfolio serves three main clinical areas: biosurgery for complex wound care, orthopaedics for sports medicine and bone graft substitutes, and dental applications for tissue and bone repair. Key products include DermaPure®, OrthoPure® XT, and the Matrix® line of bone graft substitutes.

Recent filings

Filing Released Lang Actions
First Asset Match auction nearing close
Regulatory Filings
2026-02-23 English
Update re. review of previous financial position
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Tissue Regenix Group PLC regarding an internal investigation into corporate governance concerns and financial reporting issues. It does not fit into specific categories like financial results, dividends, or director dealings. As it is a general regulatory announcement regarding company operations and governance investigations, it falls under the RNS (Regulatory Filings) category.
2026-01-16 English
Secondary Trading Following Cancellation
Regulatory Filings
2026-01-07 English
Result of General Meeting and Cancellation
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting, specifically detailing the proxy votes for various resolutions. It also includes a section on the cancellation of the company's admission to trading on AIM. While it contains voting results (DVA), the document also explicitly announces a delisting (DLST). Given the primary focus on the outcome of the General Meeting and the subsequent corporate actions, 'DVA' is the most accurate classification for the voting results, but since the document covers multiple regulatory events including delisting, 'DVA' remains the most specific category for the meeting results provided.
2025-12-22 English
Update re. proposed cancellation of shares
Regulatory Filings Classification · 1% confidence The document is an official announcement from Tissue Regenix Group plc regarding the proposed cancellation of its shares from trading and the subsequent implementation of a matched bargain facility. It explicitly references a previous announcement and provides updates on the company's trading status and financial position. Since the document is a short regulatory announcement regarding the status of the company's listing and shares, it falls under the 'Delisting Announcement' category.
2025-12-08 English
Proposed £17.5m CLN raise, cancellation of Trading
Regulatory Filings Classification · 1% confidence The document is a formal announcement from Tissue Regenix Group PLC regarding a proposed fundraising (Secured Convertible Loan Notes), a delisting from AIM, and a re-registration as a private company. It includes a notice of a General Meeting to vote on these resolutions. While it contains significant details, it functions as a regulatory announcement (RNS) notifying the market of these corporate actions and the publication of a circular. It fits the 'Regulatory Filings' (RNS) category as it is a formal market announcement of multiple corporate events including delisting and financing.
2025-12-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.